2؉ by the protein-tyrosine kinase, Syk. Syk, recruited to the clustered BCR, becomes phosphorylated on three tyrosines (Tyr-317, Tyr-342, and Tyr-346) located within the linker region that separates the C-terminal catalytic domain from the N-terminal tandem Src homology 2 domains. Phosphorylation within the linker region can be either activating or inhibitory to Ca 2؉ mobilization depending on the sites that are modified. Syk that is not phosphorylated on linker region tyrosines couples the BCR to Ca 2؉ mobilization through a phosphoinositide 3-kinase-dependent pathway. The phosphorylation of Tyr-342 and -346 enhances the phosphorylation and activation of phospholipase C-␥ and the early phase of Ca 2؉ mobilization via a phosphoinositide 3-kinase-independent pathway. The phosphorylation of Tyr-317 strongly dampens the Ca 2؉ signal. In cells that lack the Src family kinase, Lyn, the phosphorylation of the inhibitory Tyr-317 is suppressed leading to elevated production of inositol 1,4,5-trisphosphate and an amplified Ca 2؉ signal. This provides a novel mechanism by which Lyn functions as an inhibitor of BCR-stimulated signaling. Thus, Syk and Lyn combine to determine the pathway through which the BCR is coupled to Ca 2؉ mobilization as well as the magnitude and duration of the Ca 2؉ flux.
The B cell antigen receptor (BCR) is coupled to the mobilization of Ca
2؉ by the protein-tyrosine kinase, Syk. Syk, recruited to the clustered BCR, becomes phosphorylated on three tyrosines (Tyr-317, Tyr-342, and Tyr-346) located within the linker region that separates the C-terminal catalytic domain from the N-terminal tandem Src homology 2 domains. Phosphorylation within the linker region can be either activating or inhibitory to Ca 2؉ mobilization depending on the sites that are modified. Syk that is not phosphorylated on linker region tyrosines couples the BCR to Ca 2؉ mobilization through a phosphoinositide 3-kinase-dependent pathway. The phosphorylation of Tyr-342 and -346 enhances the phosphorylation and activation of phospholipase C-␥ and the early phase of Ca 2؉ mobilization via a phosphoinositide 3-kinase-independent pathway. The phosphorylation of Tyr-317 strongly dampens the Ca 2؉ signal. In cells that lack the Src family kinase, Lyn, the phosphorylation of the inhibitory Tyr-317 is suppressed leading to elevated production of inositol 1,4,5-trisphosphate and an amplified Ca 2؉ signal. This provides a novel mechanism by which Lyn functions as an inhibitor of BCR-stimulated signaling. Thus, Syk and Lyn combine to determine the pathway through which the BCR is coupled to Ca 2؉ mobilization as well as the magnitude and duration of the Ca 2؉ flux.
The activation of B lymphocytes is initiated when the B cell receptor for antigen (BCR) 1 is aggregated by interactions with polyclonal antigens. The cytoplasmic domains of the Ig-␣ and Ig-␤ components of the BCR complex link the receptor to cytoplasmic protein-tyrosine kinases, the activation of which elicits a cascade of biochemical responses that include the mobilization of Ca 2ϩ from intracellular stores mediated by inositol 1,4,5-trisphosphate (IP 3 )-gated ion channels followed by entry of extracellular Ca 2ϩ through store-operated channels (1-4). The protein-tyrosine kinases activated most proximal to the receptor are Syk and Lyn. Syk is a positive effector of BCRstimulated responses, and the disruption of this gene results in pronounced defects in Ca 2ϩ signaling and B cell development (5) (6) (7) . Current models propose that Syk, activated following BCR clustering, activates phosphoinositide 3-kinase (PI3K), which generates phosphatidylinositol 3,4,5-trisphosphate allowing for the recruitment of the Tec family kinase, Btk, via its pleckstrin homology domain to the plasma membrane (8 -10) . Syk also phosphorylates the adaptor protein, BLNK, on the tyrosines required for binding both phospholipase C␥ (PLC␥) and Btk (11) (12) (13) (14) . The combined actions of Syk and Btk to phosphorylate PLC␥ are thought to be required for its optimal activation, leading to the production of IP 3 (2, 4) .
The picture that is emerging of the role of Lyn in mediating BCR-dependent signaling is more complicated with both positive and negative roles assigned to this Src family kinase. Lyn is thought to aid in the recruitment of Syk to the BCR through the phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) on the cytoplasmic tails of Ig-␣ and Ig-␤ with which the tandem SH2 domains of Syk interact. However, although signaling from the BCR leading to the production of IP 3 and the mobilization of Ca 2ϩ is delayed in B cells lacking Lyn, the Ca 2ϩ flux is actually amplified and prolonged (7, 15, 16) . As a consequence, B cells from Lyn-deficient mice are hyper-responsive to IgM cross-linking, which leads to a hyperactivation of ERK1, ERK2, MEK1, and c-Jun N-terminal kinase and a hyperproliferative response (15, 17) . This inhibitory effect of Lyn on BCR-mediated signaling is attributed, in part, to its ability to phosphorylate immunoreceptor tyrosinebased inhibitory motifs (ITIMs) on the cytoplasmic tails of inhibitory co-receptors (15, 16, 18) . The internalization of aggregated Syk-BCR complexes is also inhibited in the absence of Lyn, suggesting that a lack of receptor down-regulation contributes to the prolonged signaling response observed in Lyndeficient cells (19) .
Following its recruitment to the BCR, Syk becomes phosphorylated on multiple tyrosines, including three in the linker region that separates the tandem SH2 domains from the Cterminal catalytic domain (20) . It is thought that both Lyn and Syk contribute to this phosphorylation. The linker region residues, Tyr-317, -342, and -346, all lie within consensus sequences for recognition by Src homology 2 (SH2) domains. The phosphorylation of Tyr-317 creates a binding site for c-Cbl, an adaptor protein that serves as a negative regulator of BCRstimulated Ca 2ϩ signaling (21, 22) . In addition, the phosphorylation of Tyr-342, -346, or both creates a binding site for * This work was supported in part by United States Public Health Service Grant CA37372 from the NCI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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§ To whom correspondence should be addressed: Dept. PLC␥ (23) . Thus, the direct interactions of these negative and positive mediators of Ca 2ϩ signaling with Syk could also help determine the nature of the Ca 2ϩ flux induced by BCR engagement.
In this study we developed assays suitable for distinguishing between signaling events supported by different site-directed mutants of Syk that would reveal the effects of the two linker region sites of protein-protein interaction. We demonstrate that elimination of the negative regulatory site at Tyr-317 greatly enhances the BCR-stimulated phosphorylation of PLC␥, the production of IP 3 , and the amplitude and duration of the Ca 2ϩ flux. This enhanced PLC␥ phosphorylation and IP 3 production is reduced, however, by elimination of Tyr-342 and -346. Mobilization of Ca 2ϩ and activation of NFAT are strongly inhibited by the PI3K inhibitor, wortmannin, in cells expressing any form of Syk lacking Tyr-342 and -346, but an alternative pathway independent of PI3K leading to the mobilization of Ca 2ϩ exists for forms of Syk containing the PLC␥-binding site. Thus, the differential phosphorylation of Syk can determine the pathway by which the BCR is coupled to the regulation of intracellular Ca 2ϩ . Interestingly, in Lyn-deficient cells, the phosphorylation of Tyr-317 is greatly depressed and much of the inhibitory effect of the presence of Tyr-317 is lost, providing an additional mechanism by which Lyn functions as a negative regulator of B cell signaling.
EXPERIMENTAL PROCEDURES
Cells-DT40 B cells lacking Syk or both Syk and Lyn were generously provided by Drs. T. Kurosaki (Kansai Medical University) and E. Puré (Wistar Institute). Cells were cultured in RPMI 1640 media supplemented with 10% heat-inactivated fetal calf serum, 1% chicken serum, 50 M 2-mercaptoethanol, 1 mM sodium pyruvate, 100 IU/ml penicillin G, and 100 g/ml streptomycin. Myc epitope-tagged Syk was expressed in transiently transfected cells and stable cell lines using the pGEM/EPB vector (24) as described previously (25) . cDNAs for the expression of site-directed mutants were prepared using the Transformer mutagenesis kit (CLONTECH). Clones were analyzed for levels of cell surface IgM by flow cytometry using a fluorescein-labeled goat anti-chicken IgM antibody (Bethyl Laboratories). Multiple clones expressing each mutant form of Syk were isolated. Syk expression levels were determined by immunoblotting proteins from cell lysates with anti-Syk antisera prepared as described (26) .
Measurement of NFAT Activity-Cells were transfected with 15-20 g of Syk expression plasmid and 10 -15 g of an NFAT-luciferase reporter construct (pNFAT Luc (Stratagene)). Cells were activated 24 -48 h post-transfection with goat anti-chicken IgM at 10 g/ml or as indicated or with a combination of PMA (50 ng/ml) and ionomycin (1.0 M) for 6 h at 37°C. Luciferase activity was determined using the luciferase assay system kit (Promega). For some experiments, cells were treated with wortmannin at a concentration of 100 nM or Me 2 SO vehicle alone for 30 min prior to addition of the anti-IgM antibody.
Immunoprecipitation and Western Blotting-Cells (1 ϫ 10 7 /ml) were stimulated with or without the monoclonal anti-IgM antibody (M4) (Southern Biotechnology) (5 g/ml) for 10 min at 37°C and then lysed with buffer containing 50 mM Tris/HCl, pH 7.3, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM sodium orthovanadate, 10 g/ml aprotinin, and 10 g/ml leupeptin. Immunoprecipitations and Western blots were performed using anti-phosphotyrosine (4G10) (Upstate Biotechnology, Inc.), anti-PLC␥2 (Santa Cruz Biotechnology), anti-Btk (BD PharMingen), or anti-BLNK antibodies (generously provided by Dr. A. Chan, Washington University, St. Louis, MO). Proteins in immune complexes were separated by SDS-PAGE, transferred to Immobilon-P membranes (Millipore), and detected using the indicated antibodies and ECL detection reagents (Amersham Biosciences).
IP 3 Production and Ca 2ϩ Mobilization-Levels of IP 3 were determined using a competitive receptor-binding assay (Amersham Biosciences) following the manufacturer's protocol. Cells (4 ϫ 10 6 /ml) were stimulated with the monoclonal anti-IgM (M4) antibody (10 g/ml) for 10 min at 37°C. Intracellular Ca 2ϩ was quantified in cells (3 ϫ 10 6 /ml) washed with Hanks' balanced salt solution supplemented with 27.5 mM Tris/HCl, pH 7.3, 1.87 mM CaCl 2 , 12.2 mM glucose, and 1% bovine serum albumin and loaded with 4 g Fluo-3AM (Molecular Probes) for 30 min at 37°C. Fluorescence was monitored by flow cytometry before and after the addition of 10 g of goat anti-chicken IgM or 1 M ionomycin.
For some cells, 100 nM wortmannin was added along with the Fluo-3AM. The activity of PI3K in vitro was determined essentially as described (27) .
Phosphopeptide Mapping-Syk(WT) or one of the various mutant versions was immunoprecipitated from lysates of the appropriate stable cell lines and autophosphorylated in vitro by incubation of the immune complex in buffer containing [␥-
32 P]ATP. The preparation of tryptic phosphopeptides from in vitro autophosphorylated Syk and their separation by alkaline polyacrylamide gel electrophoresis was performed as described (20, 28) .
RESULTS

Effect of the Elimination of Syk Linker Region
Tyrosines on the BCR-dependent Activation of NFAT-The Syk linker region possesses two sites involved in phosphotyrosine-mediated protein-protein interactions, one at Tyr-317 and a second at Tyr-342 and -346. To determine how these Syk linker region tyrosines participate in B cell signaling, we first examined the ability of site-directed mutants of Syk lacking Tyr-317, both Tyr-342 and Tyr-346, or all three tyrosines to couple the BCR to the activation of NFAT, a transcription factor regulated primarily through prolonged increases in intracellular Ca 2ϩ . In Syk-deficient DT40 B cells, BCR cross-linking is uncoupled from Ca 2ϩ mobilization and from the activation of NFAT (7, 20) . As shown in Fig. 1A , transient re-expression of Syk(WT), which has all three linker region tyrosines intact, restored receptor-stimulated NFAT activity to Syk-deficient cells as measured by the production of luciferase from a co-transfected NFAT-luciferase reporter construct. Substitution of phenylalanine for Tyr-317 (referred to as Syk(Y317F)) enhanced the ability of Syk to couple the BCR to the activation of NFAT as reported previously (22) . In this assay, the replacement of Tyr-342 and -346 with phenylalanines (referred to as Syk(Y342F/Y346F)) had no significant effect on the activation of NFAT when compared with Syk(WT). Elimination of all three sites of linker region tyrosine phosphorylation (referred to as Syk(F3)) led to an enhanced activation of NFAT that was similar to that observed for Syk(Y317F). Thus, phosphorylation of Syk within the linker region was not required for coupling the BCR to the activation of NFAT and removal of the inhibitory site at Tyr-317 enhanced signaling.
Whereas an inhibitory role for Tyr-317 in B cell signaling was expected, the absence of an obvious role for Tyr-342 and -346 was not. To examine more closely a role for these tyrosines, we compared the abilities of Syk(Y317F), which retains these two sites of phosphorylation, and Syk(F3), which lacks these sites, to support the BCR-stimulated activation of NFAT using a variety of concentrations of anti-IgM antibody. At high concentrations of antibody, both mutants coupled the BCR to the activation of NFAT to a greater extent than Syk(WT), as expected (Fig. 1B) . However, a marked difference in the relative abilities of Syk(F3) and Syk(Y317F) to couple the BCR to the activation of NFAT was observed at low concentrations of anti-IgM. The dose-response curve for cells expressing Syk(Y317F) was shifted dramatically toward lower concentrations of activating antibody. This reduction in the threshold for activation required the presence of Tyr-342 and -346 because cells expressing Syk(F3) were not hypersensitive to the activating antibody, although equivalent levels of kinase were expressed. These results indicated that, in the absence of phosphorylation at Tyr-317 and at low concentrations of activating antibody, the presence of Tyr-342 and -346 was important to the ability of Syk to couple the BCR to the activation of NFAT.
Effect of the Elimination of Tyr-342 and -346 on the Receptormediated Tyrosine-phosphorylation of PLC␥--To explore the molecular basis for the different signaling activities of Syk(Y317F) and Syk(F3), we compared the profile of proteins phosphorylated on tyrosine following engagement of the BCR in cells expressing each mutant form of Syk. For these experiments, stable cell lines lacking endogenous Syk were prepared, each expressing a cDNA encoding a mutant form of Syk driven by a B cell-specific promoter. Clones that expressed comparable levels of Syk mutant protein as determined by Western blotting with anti-Syk antibodies ( Fig. 2A) and comparable levels of surface IgM as determined by fluorescenceactivated cell sorter analysis (data not shown) were isolated.
Cells expressing Syk(Y317F) and Syk(F3) were left untreated or activated with anti-IgM antibodies. Phosphotyrosine-containing proteins were separated by SDS-PAGE and detected by Western blotting with anti-phosphotyrosine antibodies. A comparison of the profile of tyrosine-phosphorylated proteins from cells expressing the two forms of Syk is shown in Fig. 2B . Receptor cross-linking led to the enhanced phosphorylation of multiple proteins on tyrosine in both cell types. The tyrosine-phosphorylation of Syk(F3) itself was reduced as compared with Syk(Y317F), as might reasonably be expected because of the loss of two sites of phosphorylation. Among substrates other than Syk, the most noticeable difference between the cell lines was the presence of a tyrosine-phosphorylated protein migrating at M r ϭ 150,000. Stripping and reprobing the membrane with a specific antibody identified this protein as PLC␥. The tyrosine-phosphorylation of PLC␥ was robust in anti-IgM-treated cells expressing Syk(Y317F) but was reduced by comparison in cells expressing Syk(F3). These data suggest that the phosphorylation of PLC␥ is enhanced by the phosphorylation of Syk on Tyr-342 and -346, which constitute the PLC␥-binding site, and that this might account for the enhanced signaling capacity of Syk(Y317F) as compared with Syk(F3).
To compare the phosphorylation of PLC␥ in Syk(Y317F)-expressing cells to that in cells expressing mutants of Syk that retained Tyr-317, we also prepared and examined stable cell lines expressing Syk(Y342F/Y346F) and Syk(WT). These stable cell lines had levels of Syk protein ( Fig. 2C ) and surface IgM (data not shown) comparable with the cells described above. The receptor-mediated phosphorylation of PLC␥ in Syk(Y317F)-expressing cells was enhanced as compared with Syk-deficient cells expressing either Syk(Y342F/ Y346F) or Syk(WT) (Fig. 2D) . Thus, the presence of Tyr-317 reduces, whereas the presence of Tyr-342 and -346 enhances, the phosphorylation of PLC␥ on tyrosine.
Role of Syk Linker Region Tyrosines in the Regulation of IP 3 Synthesis and the Mobilization of Ca
2ϩ -Differences in the receptor-mediated phosphorylation of PLC␥ in cells expressing different mutants of Syk suggested that the BCR-stimulated production of IP 3 and mobilization of Ca 2ϩ , second messengers produced in response to the activation of PLC␥, would also be altered by the elimination of specific linker region sites of tyrosine phosphorylation. We first examined receptor-mediated production of IP 3 in the various stable cell lines. Crosslinking the BCR in Syk-deficient cells failed to result in the production of measurable amounts of IP 3 as determined by a competitive receptor-binding assay (Fig. 3A) . The production of IP 3 could be restored by re-expression of Syk(WT) to the same extent as that observed in wild-type DT40 cells expressing the endogenous chicken enzyme. BCR-stimulated production of IP 3 was then compared in the stable cell lines expressing the various forms of Syk (Fig. 3B ). The level of IP 3 produced in response to receptor aggregation was increased dramatically in cells expressing Syk(Y317F) as compared with cells expressing Syk(WT). As observed in cells expressing Syk(F3), this enhanced production of IP 3 that resulted from the elimination of the inhibitory phosphorylation site at Tyr-317 was reduced considerably by the additional elimination of Tyr-342 and -346, indicating the importance of these two residues for coupling Syk to the activation of PLC␥ and production of IP 3 . No significant difference in IP 3 levels could be detected between cells expressing Syk(WT) and Syk(Y342F/Y346F), but these levels were quite low in comparison to cells expressing Syk(Y317F). Thus, the level of production of IP 3 correlated well with the relative abilities of each form of Syk to couple the receptor to the phosphorylation of PLC␥.
Because the production of IP 3 leads to the release of Ca expressing Syk(WT). This response was similar to that observed in wild-type DT40 B cells expressing endogenous Syk (data not shown). 2؉ . A, Syk-deficient DT40 (SykϪ), wild-type DT40 (DT40), or Syk-deficient DT40 cells expressing Syk(WT) (WT) were stimulated with anti-IgM (M4) antibodies (5 g/ml) for 10 min. Cell extracts were prepared and assayed for levels of IP 3 . B, cells expressing Syk(WT), Syk(F3), Syk(Y317F), or Syk(Y342F/Y346F) were stimulated for 10 min with anti-IgM (M4) antibodies (5 g/ml) and assayed for the production of IP 3 stimulated Ca 2ϩ mobilization in cells expressing Syk(Y342F/ Y346F) was similar to the response of Syk(WT)-expressing cells, although the initial rise in Ca 2ϩ consistently occurred at a slower rate in the absence of these two sites of phosphorylation. These results suggest that the phosphorylation of Syk on Tyr-342 and -346 enhances the magnitude of the initial phase of Ca 2ϩ mobilization, whereas the phosphorylation of Tyr-317 acts to significantly dampen the Ca 2ϩ response.
Role of Syk Linker Region Tyrosines in the Receptor-mediated
Phosphorylation of BLNK-Cells expressing Syk(F3), which lacks all of the in vivo sites of tyrosine-phosphorylation that have been identified within the linker region, clearly retain the ability to mobilize Ca 2ϩ in response to receptor clustering. Thus, a pathway involving components that function independently of a direct interaction with phosphotyrosines within the linker must exist to couple the BCR to PLC␥.
BLNK is an important substrate for Syk that is phosphorylated following engagement of the BCR and serves as an adaptor protein that binds SH2 domains of both PLC␥ and the Tec family kinase, Btk (11) (12) (13) . The extent to which BLNK was phosphorylated in cells expressing the various Syk mutants was compared by immunoprecipitating BLNK from lysates of untreated or anti-IgM-treated cells and assessing its degree of tyrosine phosphorylation by a Western blot using an antibody against phosphotyrosine. Interestingly, BLNK was phosphorylated most extensively in cells expressing Syk(F3), which lacks all three linker region tyrosines (Fig. 4A) . In cells expressing Syk(Y317F), BLNK phosphorylation was less than that observed in cells expressing Syk(F3) but was elevated as compared with cells expressing Syk(WT), which exhibited the lowest level of BLNK phosphorylation. The differences in BLNK phosphorylation were observed even though equivalent amounts of BLNK protein were immunoprecipitated from each cell. Thus, unlike PLC␥, the robust phosphorylation of BLNK on tyrosine following BCR cross-linking by Syk mutants lacking Tyr-317 does not require Tyr-342 or -346.
Role of Syk Linker Region Tyrosines in Coupling the BCR to a PI3K-independent Signaling
Pathway-Genetic studies indicate that PI3K is an important component of the signaling complex that couples the BCR to the mobilization of Ca 2ϩ (29 -31) . PI3K is activated downstream from Syk in B cell signaling (8) and is required for the subsequent activation of the pleckstrin homology domain-containing protein kinase, Btk (9) . In fact, Btk, as detected by immunoblotting with both anti-phosphotyrosine and anti-Btk antibodies, was present at similar levels in anti-phosphotyrosine immune complexes isolated from the lysates of anti-IgM-activated cells containing each of the four forms of Syk (Fig. 4B) , suggesting that it could be activated in all four stable cell lines. We were, however, unable to identify an antibody that could efficiently immunoprecipitate Btk from DT40 cell lysates, making it difficult to assess accurately its true extent of activation. To examine the importance of the PI3K pathway to signaling in cells expressing the various Syk mutants, we examined the effects of wortmannin, a potent inhibitor of PI3K, on the BCR-stimulated activation of NFAT in Syk-deficient DT40 B cells transiently transfected with plasmids for the expression of each mutant form of Syk and the pNFAT Luc reporter construct. As shown in Fig. 4C , BCR-stimulated signaling in cells expressing different mutant forms of Syk exhibited different sensitivities to wortmannin. At a concentration of 100 nM, wortmannin inhibited the Syk(WT)-mediated activation of NFAT by ϳ50%. Interestingly, the activation of NFAT mediated by Syk(Y342F/ Y346F) was inhibited by greater than 80%. Thus, even though NFAT was activated to a similar extent in the absence of wortmannin for cells expressing these two kinases, differences in the pathways used could be distinguished in the presence of a PI3K inhibitor. Similar results were obtained when 10 M LY294002 was used as a PI3K inhibitor (data not shown).
A similar difference was observed in cells expressing Syk(Y317F) versus Syk(F3). Although the receptor-stimulated activations of NFAT were approximately equivalent in cells expressing the two kinases, cells expressing Syk(Y317F) were relatively insensitive to wortmannin (18% inhibition), and those expressing Syk(F3) were strongly inhibited (80%). These results indicated that signaling in cells expressing forms of Syk lacking Tyr-342 and -346 was more sensitive to inhibition by wortmannin than in cells expressing a form of Syk that retained this PLC␥-binding site.
The effect of wortmannin on Ca 2ϩ mobilization was examined to determine whether the differential sensitivity of cells to the inhibition of NFAT activity correlated with an inhibition of Ca 2ϩ signaling. Stable cell lines expressing the various mutant forms of Syk were loaded with Fluo-3 and activated by treatment with anti-IgM antibodies in the presence or absence of wortmannin. In general, wortmannin inhibited BCR-stimulated Ca 2ϩ mobilization in all cells examined (Fig. 4D) . However, once again, there were substantial differences in the sensitivity of each cell line to wortmannin. Ca 2ϩ mobilization was nearly completely abrogated by wortmannin in cells expressing Syk(Y342F/Y346F) or Syk(F3), but only partially inhibited in cells expressing Syk(WT) and Syk(Y317F). Thus, cells expressing a form of Syk that retains Tyr-342 and Tyr-346 can still couple the BCR to Ca 2ϩ mobilization and, hence, to the activation of NFAT, in the absence of the PI3K pathway.
To verify that wortmannin at a concentration of 100 nM was sufficient to inhibit effectively the activity of PI3K, we treated DT40 cells expressing Syk(WT) with the protein-tyrosine phosphatase inhibitor, pervanadate, to induce the tyrosine phosphorylation of PI3K, in the presence or absence of wortmannin. Tyrosine-phosphorylated proteins were immunoprecipitated with anti-phosphotyrosine antibodies, and the resulting immune complexes were assayed for PI3K activity (27) . PI3K activity in the immune complexes was robust when isolated from pervanadate-treated cells but was completely lost from immune complexes isolated from cells treated with both pervanadate and 100 nM wortmannin (data not shown).
Effect of Lyn Expression on the Phosphorylation of Syk Linker Region Tyrosines-Our data indicate that the differential phosphorylation of Syk on linker region tyrosines plays an important role in determining the pathways through which the BCR is coupled to downstream signaling events. Because Lyn has both positive and negative effects on signaling in B cells and can catalyze the phosphorylation of Syk, we examined more closely a role for Lyn in Syk-dependent signaling. To examine signaling in the absence of Lyn, we generated stable cell lines deficient in both endogenous Syk and Lyn but expressing Syk(WT), Syk(Y317F), or Syk(Y342F/Y346F). Cell lines were selected that expressed comparable amounts of Syk as determined by Western blotting with anti-Syk antibodies (Fig. 5A, upper panel) and comparable amounts of surface IgM as measured by fluorescence-activated cell sorter (data not shown). The expression level of Syk mutants (Fig. 5A, lower  panel) and surface IgM (data not shown) in the Lyn-deficient cells was comparable with the level of expression in the Lynexpressing cell lines described above.
In vitro, Syk can catalyze an autophosphorylation reaction that leads to the modification of all three linker region sites (32) . To determine whether the removal of specific tyrosines compromised the ability of Syk to catalyze the autophosphorylation of the remaining linker region sites, we immunoprecipitated each form of Syk from the lysates of stably transfected cells and incubated the resulting immune complexes in the presence of [␥-
32 P]ATP. The autophosphorylated kinases were separated by SDS-PAGE, transferred to nitrocellulose, and then digested extensively with trypsin. The resulting phosphopeptides were separated by electrophoresis on 40% alkaline polyacrylamide gels and detected by autoradiography (Fig. 5B) . The migration positions of the major phosphotyrosine-containing peptides had been identified previously (20) , and the tyrosines that each contains are indicated in Fig. 5B (note that Tyr-342 and Tyr-346 are located on a single phosphopeptide that migrates as either a singly or doubly phosphorylated form). Syk(WT) was able to catalyze the autophosphorylation of all three linker region tyrosines. Syk(Y317F) retained the ability to catalyze the autophosphorylation of Tyr-342 and Tyr-346. Similarly, Syk(Y342F/Y346F) retained the ability to autophosphorylate at Tyr-317. Thus, the removal of any individual set of phosphorylation sites did not adversely alter the accessibility of the other sites to autophosphorylation. This analysis also verified, at the protein level, the absence of the predicted, specific sites of phosphorylation in the various Syk mutants. Previous phosphopeptide mapping studies have shown that the in vitro phosphorylation of Syk on Tyr-317, but not on Tyr-342 or -346, results in a retardation of its mobility on SDS-polyacrylamide gels relative to the unphosphorylated form (20) . To confirm that this selective shift in mobility also occurs when Syk is phosphorylated in intact cells, we monitored by Western blotting the tyrosine phosphorylation of Syk as a function of receptor aggregation in cells containing endogenous Lyn and expressing either Syk(Y342F/Y346F) or Syk(Y317F), which can or cannot be phosphorylated on Tyr-317, respectively (Fig. 5C ). As expected, tyrosine-phosphorylated Syk(Y342F/Y346F) from anti-IgM-treated cells migrated with a reduced electrophoretic mobility as compared with Syk(Y317F). Thus, an altered, slower migration of Syk is also indicative of its phosphorylation on Tyr-317 in intact cells.
We then examined the phosphorylation of these various forms of Syk on tyrosine as a function of time in response to receptor engagement in cells either expressing or lacking endogenous Lyn. As shown in Fig. 5D , Syk(WT) was phosphorylated transiently on tyrosine following BCR cross-linking in cells that expressed Lyn. The migration position of the tyrosine-phosphorylated Syk indicated that the protein was phosphorylated on Tyr-317 (and at other sites as determined previously (20)). In cells that lacked Lyn, the tyrosine phosphorylation of Syk was elevated and persistent and could still be observed 60 min following receptor engagement. Interestingly, the most rapidly migrating form of tyrosine-phosphorylated Syk(WT), the form that lacks phosphate on Tyr-317, was observed only in Lyn-deficient cells indicating that a substantial fraction of the protein was not phosphorylated at this site. This result suggests a defect in the phosphorylation of Syk on Tyr-317 in cells lacking Lyn.
The phosphorylation of Syk(Y317F) on tyrosine following receptor engagement was pronounced in both the Lyn-expressing and Lyn-deficient cells but was more protracted in the cells lacking Lyn. The migration position of tyrosine-phosphorylated Syk(Y317F) was consistent with a lack of phosphorylation at Tyr-317. Thus, sites on Syk other than Tyr-317 clearly are phosphorylated following receptor engagement whether or not Lyn is expressed.
The tyrosine phosphorylation of Syk(Y342F/Y346F) was transient but readily observed in anti-IgM-treated cells that expressed Lyn. The migration position of the tyrosine-phosphorylated protein was consistent with its phosphorylation on Tyr-317 (i.e. it exhibited a retarded mobility). However, the phosphorylation of Syk(Y342F/Y346F) was barely detectable in cells that lacked Lyn indicating again that the phosphorylation of Syk on Tyr-317 is reduced considerably in these cells. These data combine to indicate that Syk is readily phosphorylated on Tyr-342 and -346 in Lyn-deficient cells but is poorly phosphorylated on Tyr-317.
Enhancement of Signaling through Wild-type Syk in Lyndeficient Cells-This reduced phosphorylation of Syk on Tyr-317 relative to other sites suggested that the inhibitory effects normally associated with the presence of Tyr-317 in a Lynexpressing cell might be reduced correspondingly in a Lyndeficient cell. Thus, we reasoned that Syk(WT) might signal more like Syk(Y317F) when expressed in cells lacking Lyn. To examine this, we compared the abilities of Syk(Y317F) and Syk(WT) to restore receptor-stimulated activation of NFAT to cells deficient in Lyn. For these studies, Syk/Lyn-deficient cells were transiently transfected with constructs coding for Syk(WT) or Syk(Y317F) along with the pNFAT Luc reporter plasmid. As a control, Syk-deficient cells containing endogenous Lyn were also transfected with the plasmid coding for Syk(WT). As shown by an increase in luciferase expression, the BCR-stimulated activation of NFAT was much higher when Syk(WT) was introduced into Syk/Lyn-deficient cells than into Syk-deficient cells (Fig. 6A) . However, signaling in the absence of Lyn was not enhanced further by the removal of Tyr-317 as evidenced by the similar levels of NFAT activity observed following receptor clustering in Syk/Lyn-deficient cells expressing Syk(WT) versus Syk(Y317F). Syk(WT) and Syk(Y317F) were expressed at similar levels and supported similar extents of NFAT activation at multiple concentrations of anti-IgM in cells lacking Lyn (Fig. 6B) . This is in contrast to what was observed in Lyn-expressing cells where Syk(Y317F) was more active than Syk(WT), especially at low doses of activating antibody (Fig. 1B) .
We then examined the effects of wortmannin on BCR-stimulated signaling mediated by Syk(WT) and Syk(Y317F) in the Syk/Lyn-deficient cells (Fig. 6A ). Wortmannin at a concentration of 100 nM had little effect on the activation of NFAT in cells expressing either Syk(WT) (15% inhibition) or Syk(Y317F) (8% inhibition). This low sensitivity to wortmannin is similar to that observed for Lyn-expressing cells containing Syk(Y317F) (Fig. 4B) . Thus, Syk(WT) and Syk(Y317F) appear to signal in a similar fashion in Lyn-deficient cells.
To examine events occurring more rapidly following receptor cross-linking, we evaluated the effects of BCR clustering on the generation of IP 3 and the mobilization of Ca 2ϩ in Syk/Lyndeficient cells expressing the various Syk mutants. For the measurement of IP 3 production, we used the stable cell lines expressing either Syk(WT) or Syk(Y317F), but lacking endogenous Syk and Lyn, and compared these to cells expressing Syk(WT) and endogenous Lyn. Cells were activated by treatment with anti-IgM antibodies, and the levels of IP 3 were determined (Fig. 7A) . The production of IP 3 was elevated in cells expressing Syk(WT) in the absence as compared with the presence of endogenous Lyn. This level of IP 3 production was similar to that observed earlier in the Lyn-expressing cells that contained Syk(Y317F). The elimination of Tyr-317 led to a further 3-fold enhancement in IP 3 production in Syk/Lyn-deficient cells, likely due to the fact that some phosphorylation of Tyr-317 can occur in the Lyn-deficient cells. These data indicate, however, that the production of IP 3 in Lyn-deficient cells is elevated regardless of whether or not the expressed kinase contains or lacks Tyr-317.
We further examined the abilities of Syk(WT) and Syk(Y317F) to couple the BCR to the phosphorylation of PLC␥ in Lyn-deficient and Lyn-expressing cells. In this experiment, tyrosine-phosphorylated proteins were recovered from lysates of unstimulated or anti-IgM-activated cells and immunoblotted with antibodies against either phosphotyrosine or PLC␥. As shown earlier (Fig. 2D) , the phosphorylation of PLC␥ on tyrosine in response to receptor cross-linking was robust in Lyncontaining cells expressing Syk(Y317F) but weak in cells expressing Syk(WT). However, in cells lacking Lyn, the phosphorylation of PLC␥ was easily observed regardless of the form of Syk (i.e. Syk(WT) or Syk(Y317F)) that was expressed.
As a final comparison of signaling between Syk(WT) and Syk(Y317F) in Lyn-deficient cells, we examined the ability of each to couple the BCR to the mobilization of Ca 2ϩ . The Syk/ Lyn-deficient cells expressing Syk(WT) or Syk(Y317F) were loaded with Fluo-3 and then changes in fluorescence were monitored as a function of time following receptor cross-link- ing. These results are shown in Fig. 7C . In cells lacking Lyn, the mobilization of Ca 2ϩ in response to BCR engagement was delayed for ϳ50 s as compared with cells expressing Lyn (Fig.  3C ) regardless of the form of Syk that was expressed. Despite this delay, the amplitude of the Ca 2ϩ flux in the Syk/Lyndeficient cells expressing Syk(WT) was enhanced and sustained and was similar to that observed in cells expressing Syk(Y317F). These results again indicate that the presence of Tyr-317 has little effect on the ability of Syk to couple the BCR to downstream responses when cells lack the Lyn kinase.
Syk(Y317F), but not Syk(Y342F/Y346F), was readily phosphorylated following receptor engagement in Lyn-deficient cells suggesting that Tyr-342 and/or -346 remain as important sites of tyrosine phosphorylation. To determine whether these sites were important for receptor-mediated Ca 2ϩ mobilization, we also examined this in Syk/Lyn-deficient cells expressing Syk(Y342F/Y346F). In contrast to Syk(WT) or Syk(Y317F), Syk(Y342F/Y346F) was unable to support a strong, early Ca 2ϩ flux (Fig. 7C ) and supported only a low level of tyrosine phosphorylation of PLC␥ (Fig. 7C, inset) . Thus, in Lyn-deficient cells, the presence of Tyr-342 and Tyr-346 is critical for coupling Syk to the activation of PLC␥ and the early mobilization of Ca 2ϩ .
DISCUSSION
The physiological response of a B lymphocyte to an antigen interacting with the B cell antigen receptor (BCR) can range from cell proliferation, to anergy, to apoptosis. The nature of the response depends on multiple factors that include the concentration of the antigen, the avidity and duration of the interaction, the extent of receptor cross-linking, and the presence or absence of additional stimuli transduced through co-receptors (33, 34) . An important consequence of receptor cross-linking is a change in the concentration of intracellular Ca 2ϩ (1) . The magnitude and duration of these Ca 2ϩ fluxes, which lead to the selective activation of subsets of transcription factors, is thought to play a major role in determining the biological outcome of receptor engagement (35, 36) . Understanding how components of the signaling machinery regulate the nature of the Ca 2ϩ flux in B cells would, therefore, provide insight as to how a single receptor can transmit both positive and negative signals. In this study, we have explored the hypothesis that the state of tyrosine-phosphorylation of Syk can contribute to the nature of the Ca 2ϩ signal that is generated in response to receptor engagement. Our data support this concept by demonstrating that the differential phosphorylation of linker region tyrosines can regulate both the amplitude of the early Ca 2ϩ flux and the duration of the Ca 2ϩ response. They further support a model whereby the Src family kinase, Lyn, utilizes the selective phosphorylation of one of these linker region tyrosines to negatively regulate responses to BCR-initiated signaling.
Following BCR cross-linking in Lyn-expressing cells, Syk is recruited to the site of the clustered receptor, leading to its activation and to its phosphorylation on at least five tyrosines, three of which are located in the linker region (20) . It is likely that activated Syk at the receptor can exist in different states of phosphorylation with regard to these tyrosines. The pathways that are activated would then depend on the subset of tyrosines that are modified. A model for visualizing these interactions is proposed in Fig. 8 .
In this model, the phosphorylation of Syk on Tyr-342 and -346 enhances the coupling of the BCR to the phosphorylation and activation of PLC␥. This is based on the observation that, in cells expressing Syk(Y317F), BCR engagement leads to an increase in the phosphorylation of PLC␥ (Fig. 2B) , an enhanced generation of IP 3 (Fig. 3B) , and an increase in the amplitude of the rapid phase of Ca 2ϩ mobilization (Fig. 3C) as compared with cells expressing Syk(F3), which lacks this putative PLC␥-binding site. The phosphorylation of Tyr-342 and -346 provides a route from the BCR to Ca 2ϩ mobilization that is independent of PI3K as shown by the fact that both Ca 2ϩ mobilization (Fig.  4D ) and NFAT activation (Fig. 4C) can occur in the presence of wortmannin in cells expressing forms of Syk that retain Tyr-342 and -346 but do not proceed efficiently in cells expressing forms of Syk that lack these sites. This likely explains why Syk is so important for regulating the initial, rapid Ca 2ϩ responses of B cells to BCR engagement and why the initial phase of Ca 2ϩ flux can occur in the absence of Btk, which is downstream of PI3K (37) (38) (39) . It is not yet known if the coupling of Syk to the rapid activation of PLC␥ requires the phosphorylation of one or both of these tyrosines. However, our preliminary examinations of the interaction of Syk-derived phosphopeptides with the C-terminal SH2 domain of PLC␥ indicate that the phosphorylation of both tyrosines is required for the highest affinity interaction.
Syk that is phosphorylated on Tyr-317 is inhibited from participating in BCR-stimulated Ca 2ϩ mobilization. Consequently, mutation of this site gives rise to amplified phosphorylation of BLNK (Fig. 4A) and PLC␥ (Fig. 2, B and C) , in- creased generation of IP 3 (Fig. 3B) , and enhanced Ca 2ϩ fluxes (Fig. 3C ). These enhancements in signaling might be explained by the loss of the binding site for c-Cbl or its homolog, Cbl-b, because elimination of this site also blocks the ability of overexpressed c-Cbl to inhibit receptor-mediated signaling in these cells (22) . This inhibition required an intact c-Cbl SH2 domain, which recognizes primary sequences containing phosphotyrosines that resemble the sequence surrounding Tyr-317 (40) . Similarly, the ability of c-Cbl to down-regulate human Syk expressed in COS cells requires both the Syk tyrosine analogous to Tyr-317 and the c-Cbl SH2 domain (21) . These greatly enhanced responses of Syk(Y317F)-expressing cells to external stimulation through the BCR may be analogous to the hyperresponsiveness of B cells from Cbl-b-deficient mice to receptor ligation (41) . These cells, like the Syk(Y317F) cells (Fig. 1B) , also display enhanced responses to low concentrations of activating anti-IgM antibody.
Syk that is not phosphorylated in the linker region can actively couple the BCR to the activation of PLC␥ and mobilization of Ca 2ϩ because these responses are intact in cells that lack endogenous Syk but express Syk(F3). The signaling pathway employed is likely to involve the BLNK adaptor protein, because its phosphorylation on tyrosine is particularly pronounced in cells expressing Syk(F3) (Fig. 4A) , and PI3K, because both the mobilization of Ca 2ϩ and activation of NFAT in these cells is particularly sensitive to the presence of wortmannin (Fig. 4, C and D) . This is an important signaling pathway in B cells because the disruption of genes for BLNK inhibits receptor-stimulated Ca 2ϩ mobilization in DT40 cells (13) and B cells from mice deficient in BLNK, and the p85␣ subunit of PI3K shows similar pronounced defects in receptor-mediated Ca 2ϩ fluxes (29 -31, 42, 43) . It is likely that the requirements for BLNK and PI3K reflect their abilities to activate the cytoplasmic protein-tyrosine kinase, Btk, because PI3K and BLNK are both required for the full activation of Btk (9, 44), and disruption of the gene for Btk results in a defective B cell phenotype similar to that observed in cells from mice deficient in either BLNK or p85␣ (45, 46) . Btk is particularly important in B cells for regulating prolonged increases in intracellular Ca 2ϩ (38) . The data provided in this study indicate that Syk can link the BCR to the mobilization of Ca 2ϩ by different pathways depending on its state of phosphorylation within the linker region. Thus, it is attractive to speculate that some of the varied physiological outcomes of receptor engagement will be a reflection of these different states of Syk phosphorylation. This would require that mechanisms exist for the differential phosphorylation of these linker region tyrosines. We sought, therefore, to identify at least one condition under which the selective phosphorylation of a subset of these sites might occur. Our study indicates that changes in the activity of Lyn might be an important determinant of which sites become phosphorylated following receptor engagement.
In the absence of Lyn, many B cells responses are enhanced, indicating that Lyn has an important role as a negative regulator of signaling. The leading candidates for the mediators of the inhibitory effects of Lyn on BCR-signaling are the B cell inhibitory receptors Fc␥RIIB and CD22. When phosphorylated on tyrosines present within their cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs), these receptors recruit directly the negative effectors of signaling, SHIP (SH2 domain-containing inositol 5-phosphatase) and SHP-1 (SH2 domain-containing phosphotyrosine phosphatase), respectively (47) . Lyn is a candidate ITIM kinase, and the tyrosine phosphorylation of both Fc␥RIIB and CD22 are reduced in Lyndeficient B cells (15) (16) (17) (18) . Accordingly, some aspects of negative signaling are blunted including the Fc␥RIIB-dependent inhibition of B cell proliferation and the CD22-dependent inhibition of Ca 2ϩ mobilization. However, other aspects of negative signaling such as the Fc␥RIIB-dependent inhibition of extracellular signal-regulated kinase activation and Ca 2ϩ responses and the CD22-dependent inhibition of extracellular signal-regulated kinase activation are largely intact in the Lyn-deficient cells (15) . Responses to the engagement of the BCR in the absence of inhibitory signals from either Fc␥RIIB or CD22 (i.e. ligation of surface IgM with F(abЈ) 2 antibodies and sequestration of CD22 by pretreatment with anti-CD22 antibodies) are still elevated in the absence of Lyn suggesting that Lyn is involved in other modes of negative regulation independent of those mediated by Fc␥RIIB/SHIP or CD22/SHP-1.
In the proposed model (Fig. 8) , Lyn contributes to the negative regulation of B cell signaling by promoting the phosphorylation of Syk on Tyr-317. Thus, the phosphorylation of Syk(Y342F/Y346F), which retains Tyr-317 as the only phosphorylatable linker region tyrosine, is poorly phosphorylated in Lyn-deficient cells but is readily phosphorylated in cells that express Lyn (Fig. 5D ). In addition, the most rapidly migrating form of tyrosine-phosphorylated Syk(WT), which lacks phosphate at Tyr-317, persists selectively in anti-IgM-treated, Lyndeficient cells. As a result, the inhibitory effects of Tyr-317 phosphorylation are largely absent in Lyn-deficient cells, and signals such as PLC␥ phosphorylation (Fig. 7B) , IP 3 production (Fig. 7A) , Ca 2ϩ mobilization (Fig. 7C) , and NFAT activation (Fig. 6 ) mediated by Syk(WT) are enhanced and now resemble those mediated by Syk(Y317F). The simplest explanation for the observed effects is that Lyn selectively catalyzes the phosphorylation of Syk on Tyr-317 as compared with Tyr-342 or -346. However, we cannot rule out the possibility of a less direct mechanism involving, perhaps, the selective actions of a phosphotyrosine phosphatase.
Whereas the phosphorylation of Syk on Tyr-317 is reduced in Lyn-deficient cells, the phosphorylation of Tyr-342 and/or -346 remains intact as observed by the robust tyrosine phosphorylation of Syk in Lyn-deficient cells expressing Syk(WT) and Syk(Y317F) but not Syk(Y342F/Y346F) (Fig. 5D) . The phosphorylation of these two sites, in the absence of extensive phosphorylation of Tyr-317, allows either Syk(WT) or Syk(Y317F) to strongly couple the BCR to the phosphorylation of PLC␥, production of IP 3 , mobilization of Ca 2ϩ , and activation of NFAT (Figs. 6 and 7) by a pathway that is independent of PI3K. In fact, this appears to be a major pathway for Ca 2ϩ mobilization in Lyn-deficient cells because both PLC␥ phosphorylation and the early phase of the receptor-stimulated Ca 2ϩ flux are reduced considerably in cells expressing Syk(Y342F/Y346F) (Fig.  7C) . As would be predicted by the model, the BCR-stimulated activation of NFAT by either Syk(WT) or Syk(Y317F) is relatively insensitive to wortmannin in Lyn-deficient cells (Fig.  6A) . Thus, it might reasonably be expected that stimuli interacting with B cells that inhibit the activity of Lyn or reduce its access to Syk would augment BCR signaling through a pathway involving PLC␥ but not PI3K. Interestingly, the clustering of the stimulatory co-receptor, CD19, which sequesters Lyn and thus reduces the phosphorylation of CD22, also augments BCR signaling by a mechanism that is insensitive to wortmannin (48) . It is possible that the sequestration of Lyn by CD19 also restricts its interactions with Syk, leading to a reduction in the phosphorylation of Tyr-317 and enhanced signaling through PLC␥, but this possibility remains to be tested.
This enhanced signaling through a PI3K-independent pathway in Lyn-deficient cells might also explain why the depletion of Lyn from murine B cells can reverse a B cell proliferation deficiency arising from the expression of a reduced level of Btk (49) . B cells from mice that have low levels of Btk, which requires PI3K for its activation, exhibit a B cell proliferation deficiency. A genetic screen designed to identify modifiers of this phenotype identified Lyn as the strongest modifier. The deletion of Lyn restored BCR-dependent cell proliferation to Btk lo cells to levels even higher than wild-type cells. Such a result might be expected if the depletion of Lyn provided an enhanced signaling pathway downstream from the BCR that did not rely on PI3K and Btk. Such a pathway is activated in the Lyn-deficient DT40 cells. Interestingly, CD22 was not a modifier, and SHIP was only a mild modifier of the Btk lo phenotype, suggesting that a loss of the Lyn/CD22/SHP-1 or Lyn/Fc␥RIIB/SHIP inhibitory pathways was not responsible for this effect. This provides further evidence that Lyn can inhibit signaling through mechanisms in addition to its ability to phosphorylate inhibitory receptors.
In addition to a qualitative difference in the phosphorylation of Syk in Lyn-expressing versus Lyn-deficient cells, there is also a considerable difference in the duration of Syk phosphorylation following receptor engagement. We think this is likely due to the prolonged association of Syk with the aggregated BCR that is observed in Lyn-deficient cells (19) . In the absence of Lyn, Syk is still recruited to the site of the cross-linked antigen receptor, but these complexes are refractory to internalization and down-regulation (19) .
These studies also provide some insight into the mechanisms that govern the unusual ability of Lyn to exert both positive and negative influences on BCR signaling. Signaling defects of Lyn-deficient DT40 B cells include a decrease in signaling through the wortmannin-sensitive pathway leading to Ca 2ϩ mobilization and a delay in the onset of the Ca 2ϩ flux following BCR engagement. A decrease in the wortmannin-sensitive (i.e. PI3K-dependent) signaling pathway may reflect a requirement in these cells for an Src family kinase to support the receptormediated, downstream activation of Btk, as has been demonstrated previously (9) . The delay in the receptor-stimulated response of Lyn-deficient cells resembles the delay in Ca 2ϩ mobilization, PLC␥ activation, and aggregation observed in platelets from Lyn-deficient mice activated through the collagen receptor, GPVI, which also signals through the recruitment of Syk to receptor ITAMs (50) . The source of this delay is not completely understood but could arise from a reduced rate of phosphorylation of ITAMs or a decrease in the rate of activation of Syk through its phosphorylation on activation loop tyrosines (51) .
